15-Keto prostaglandin E2 induces heme oxygenase-1 expression through activation of Nrf2 in human colon epithelial CCD 841 CoN cells.

作者: Ja-Young Lee , Young-Joon Surh , Hye-Kyung Na , Jeong-Eun Lee , Xiancai Zhong

DOI: 10.1016/J.ABB.2019.108162

关键词:

摘要: Prostaglandin E2 (PGE2) plays a key role in inflammation-associated carcinogenesis. NAD+-dependent 15-hydroxyprostaglandin dehydrogenase (15-PGDH) catalyzes the oxidation of 15(S)-hydroxyl group PGE2 to generate 15-keto PGE2. 15-PGDH has been known as tumor suppressor various malignancies including colon cancer. However, molecular mechanisms underlying tumor-suppressive function remain largely unresolved. In this study, we found that upregulated expression heme oxygenase-1 (HO-1), representative antioxidative and anti-inflammatory enzyme, at both transcriptional translational levels, human epithelial CCD 841 CoN cells. A redox-sensitive transcription factor, NF-E2-related factor (Nrf2) critical regulation HO-1 other cytoprotective proteins. 15-Keto induced translocation Nrf2 into nucleus antioxidant response element-driven luciferase activity. Furthermore, silencing gene abolished PGE2-induced activated AKT signaling, pharmacological inhibitor, LY294002 suppressed expression. generates reactive oxygen species which is by general N-acetyl-l-cysteine. N-acetyl-l-cysteine treatment attenuated phosphorylation GSK3β, activity Nrf2, subsequently 13,14-dihydro-15-keto lacking α,β-unsaturated carbonyl moiety failed induce intracellular production species, nuclear Nrf2. conclusion, induces through activation

参考文章(53)
Shuntaro Hara, Daisuke Kamei, Yuka Sasaki, Akemi Tanemoto, Yoshihito Nakatani, Makoto Murakami, Prostaglandin E synthases: Understanding their pathophysiological roles through mouse genetic models. Biochimie. ,vol. 92, pp. 651- 659 ,(2010) , 10.1016/J.BIOCHI.2010.02.007
Liying Dai, Denis W. King, D. Shevy Perera, David Z. Lubowski, Elizabeth Burcher, Lu Liu, Inverse Expression of Prostaglandin E2-Related Enzymes Highlights Differences Between Diverticulitis and Inflammatory Bowel Disease Digestive Diseases and Sciences. ,vol. 60, pp. 1236- 1246 ,(2015) , 10.1007/S10620-014-3478-7
Jean Y. Park, Michael H. Pillinger, Steven B. Abramson, Prostaglandin E2 synthesis and secretion: the role of PGE2 synthases. Clinical Immunology. ,vol. 119, pp. 229- 240 ,(2006) , 10.1016/J.CLIM.2006.01.016
Jesus A. Araujo, Min Zhang, Fen Yin, Heme oxygenase-1, oxidation, inflammation, and atherosclerosis. Frontiers in Pharmacology. ,vol. 3, pp. 119- 119 ,(2012) , 10.3389/FPHAR.2012.00119
Michael G. Backlund, Jason R. Mann, Vijaykumar R. Holla, F. Gregory Buchanan, Hsin-Hsiung Tai, Erik S. Musiek, Ginger L. Milne, Sharada Katkuri, Raymond N. DuBois, 15-Hydroxyprostaglandin dehydrogenase is down-regulated in colorectal cancer. Journal of Biological Chemistry. ,vol. 280, pp. 3217- 3223 ,(2005) , 10.1074/JBC.M411221200
Takuma Shiraki, Narutoshi Kamiya, Sayaka Shiki, Takashi S. Kodama, Akira Kakizuka, Hisato Jingami, α,β-Unsaturated Ketone Is a Core Moiety of Natural Ligands for Covalent Binding to Peroxisome Proliferator-activated Receptor γ Journal of Biological Chemistry. ,vol. 280, pp. 14145- 14153 ,(2005) , 10.1074/JBC.M500901200
Michael B. Sporn, Karen T. Liby, NRF2 and cancer: the good, the bad and the importance of context Nature Reviews Cancer. ,vol. 12, pp. 564- 571 ,(2012) , 10.1038/NRC3278
Tin Oo Khor, Mou-Tuan Huang, Ki Han Kwon, Jefferson Y. Chan, Bandaru S. Reddy, Ah-Ng Kong, Nrf2-Deficient Mice Have an Increased Susceptibility to Dextran Sulfate Sodium–Induced Colitis Cancer Research. ,vol. 66, pp. 11580- 11584 ,(2006) , 10.1158/0008-5472.CAN-06-3562
Yu-Hauh Wu, Tzu-Ping Ko, Rey-Ting Guo, Su-Ming Hu, Lee-Ming Chuang, Andrew H.-J. Wang, Structural Basis for Catalytic and Inhibitory Mechanisms of Human Prostaglandin Reductase PTGR2 Structure. ,vol. 16, pp. 1714- 1723 ,(2008) , 10.1016/J.STR.2008.09.007
John L. Wallace, PROSTAGLANDIAN BIOLOGY IN INFLAMMATORY BOWEL DISEASE Gastroenterology Clinics of North America. ,vol. 30, pp. 971- 980 ,(2001) , 10.1016/S0889-8553(05)70223-5